A Review of Benign Prostatic Hyperplasia

Pharmacy Tech CEU
Contact Hours: 1.0 (0.1 CEUs)

Course Summary

Within the realm of male health conditions, benign prostatic hyperplasia (BPH) is a disorder with major public health consequences. This course will review the etiology and pathophysiology of BPH and describe available treatment options in detail, including appropriate administration, mechanisms of action, side effects, and contraindications. The role of each member of the interdisciplinary team caring for patients with BPH is essential. Clinicians must evaluate the patient, consider a differential diagnosis, and provide the patient with a treatment plan that will provide the patient with the best outcome.

Course Objectives

Describe the underlying causes of benign prostatic hyperplasia (BHP)

Compare and contrast treatment options for BPH

Recall indications, contraindications, side effect profiles, and monitoring parameters for BPH treatments

I. Introduction

II. BPH: An Overview

1. Epidemiology
2. Pathophysiology
3. Etiology
4. Diagnosis
5. Medication-Related Causes of BPH

III. Management of BPH

1. Watchful Waiting
2. Pharmacologic Treatment
3. Alpha-1 Adrenergic Antagonists
4. Alpha Blocker Efficacy
5. 5-alpha Reductase Inhibitors
6. Muscarinic Receptor Antagonists (MRAs)
7. Phosphodiesterase-5 Inhibitor (PDE-5)
8. Mirabegron
9. Combination Therapy
10. Nutraceuticals
11. Surgical Interventions

IV. The Role of the Clinician

V. Summary

How to Earn Credit:
To earn credit for this course, participants must:
  1. Read the course objectives and faculty planner disclosure
  2. Read the course material
  3. Complete the post-test with a minimum score of 70% and complete the course evaluation form.
  4. Results are automatically submitted to CPE Monitor

Faculty Planner Disclosure

The following individuals were involved in the development of this activity: L. Austin Fredrickson, MD, FACP, and Susan DePasquale, MSN, PMHNP-BC. There are no financial relationships relevant to this activity to report or disclose by any of the individuals involved in the development of this activity.

Unlabeled Use Disclosures

The information provided in this course is general in nature and it is solely designed to provide participants with continuing education credit(s). This course and materials are not meant to substitute for the independent, professional judgment of any participant regarding that participant’s professional practice, including but not limited to patient assessment, diagnosis, treatment and/or health management. Medical and pharmacy practices, rules, and laws vary from state to state, and this course does not cover the laws of each state; therefore, participants must consult the laws of their state as they relate to their professional practice. Healthcare professionals, including pharmacists and pharmacy technicians, must consult with their employer, healthcare facility, hospital, or other organization, for guidelines, protocols, and procedures they are to follow. The information provided in this course does not replace those guidelines, protocols, and procedures but is for academic purposes only, and this course’s limited purpose is for the completion of continuing education credits. Participants are advised and acknowledge that information related to medications, their administration, dosing, contraindications, adverse reactions, interactions, warnings, precautions, or accepted uses are constantly changing, and any person taking this course understands that such person must make an independent review of medication information prior to any patient assessment, diagnosis, treatment and/or health management. Any discussion of off-label use of any medication, device, or procedure is informational only and such uses are not endorsed hereby. Nothing contained in this course represents the opinions, views, judgments, or conclusions of RxCe.com LLC. RxCe.com LLC is not liable or responsible to any person for any inaccuracy, error, or omission with respect to this course, or course material.

Computer Hardware/Software Requirements

Please ensure the device you plan to use meets these requirements and specifications:

  • Operating System: Windows 7,8,10, or 11 /Mac OS X 10.9 or later/iOS/Android
  • Supported Browsers: Microsoft Edge, Firefox, Google Chrome, Safari, Opera
  • A connection to the internet
  • For Live Webinars or Conferences: GoToWebinar application for iOS, Android, Mac, or PC. You cannot 'call into' a live conference.

  • Target Audience: Pharmacy Tech
  • Contact Hours: 1.0 (0.1 CEUs)
  • Activity Release Date: 3/18/2023
  • Activity Expiration Date: 3/18/2026
  • Activity Type: Knowledge
  • UAN: 0669-0000-23-045-H01-T
  • Topic: Disease State Management/Drug Therapy
  • CeBroker Number: 20-1005998


L. Austin Fredrickson, MD, FACP



The logo for the Accreditation Council for Pharmacy Education (ACPE).

RxCe.com, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

The logo for the Pharmacy Technician Certification Board (PTCB).
PTCB Course Recognition

RxCe.com, LLC, offers pharmacy technician continuing education courses for PTCB recertification. Pharmacy technician courses are indicated both in the Target Audience description and the ACPE UAN which will end with a "T".

‹‹ Back to Course List